Literature DB >> 35814036

Chemical mutagenesis and high throughput media optimization in Tolypocladium inflatum MTCC-3538 leads to enhanced production of cyclosporine A.

Vidushi Abrol1,2, Manoj Kushwaha1, Sharada Mallubhotla2, Sundeep Jaglan1,3.   

Abstract

Diethyl sulphate-based mutagenesis was performed on fungal strain Tolypocladium inflatum MTCC-3538. Two mutant morphotypes MT1-3538 and MT2-3538 were selected for further chemo-profiling studies. LCMS/MS profiling of fungal crude extract confirmed that the wild-type and mutant strains (MT1-3538, MT2-3538) were competent to produce cyclosporine A. MT2-3538 produced 2.1 fold higher cyclosporine A in comparison to the wild type. Further, LCMS-based high throughput media optimization was performed for MT2-3538 in 20 different media combinations to increase cyclosporine A yield. On the basis of ion-intensity profiling, media combination consisting of Glucose 0.1 g/L; Peptone 0.005 g/L and Valine 0.005 g/L was selected and used for up-scaling purpose. Mutant MT2-3538 with optimized media combination increased cyclosporine yield 16 fold and could potentially be exploited for commercial outcomes. Supplementary Information: The online version contains supplementary material available at 10.1007/s13205-022-03219-x. © King Abdulaziz City for Science and Technology 2022.

Entities:  

Keywords:  Chemical mutagenesis; Cyclosporine A; Diethyl sulphate (DES); Direct Infusion-Tandem Mass Spectrometry (DI-MS/MS); Tolypocladium inflatum

Year:  2022        PMID: 35814036      PMCID: PMC9256877          DOI: 10.1007/s13205-022-03219-x

Source DB:  PubMed          Journal:  3 Biotech        ISSN: 2190-5738            Impact factor:   2.893


  28 in total

Review 1.  Fungal secondary metabolism - from biochemistry to genomics.

Authors:  Nancy P Keller; Geoffrey Turner; Joan W Bennett
Journal:  Nat Rev Microbiol       Date:  2005-12       Impact factor: 60.633

2.  Strain improvement of Lentzea sp. 7887 for higher yield per unit volume on hydroxylation of cyclosporine derivative FR901459.

Authors:  Tetsuya Yabutani; Mami Tsujimoto; Shunsuke Ohira; Shiho Shimizu; Hideo Nakano
Journal:  Biosci Biotechnol Biochem       Date:  2017-04-13       Impact factor: 2.043

3.  Should cyclosporine be continued indefinitely?

Authors:  C R Stiller; G Opelz
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

4.  Statistical optimization for improved production of cyclosporin a in solid-state fermentation.

Authors:  Shrikant A Survase; Uday S Annapure; Rekha S Singhal
Journal:  J Microbiol Biotechnol       Date:  2009-11       Impact factor: 2.351

Review 5.  Genetic effects of dimethyl sulfate, diethyl sulfate, and related compounds.

Authors:  G R Hoffmann
Journal:  Mutat Res       Date:  1980-01       Impact factor: 2.433

Review 6.  Cyclosporin A in organ transplantation.

Authors:  P J Miach
Journal:  Med J Aust       Date:  1986 Aug 4-18       Impact factor: 7.738

7.  Cyclosporine A: Chemistry and Toxicity - A Review.

Authors:  Jiri Patocka; Eugenie Nepovimova; Kamil Kuca; Wenda Wu
Journal:  Curr Med Chem       Date:  2021       Impact factor: 4.530

8.  Enhancement of cyclosporin production in a Tolypocladium inflatum strain after epichlorohydrin treatment.

Authors:  S N Agathos; R Parekh
Journal:  J Biotechnol       Date:  1990-01       Impact factor: 3.307

9.  Activation of dormant secondary metabolite production by introducing neomycin resistance into the deep-sea fungus, Aspergillus versicolor ZBY-3.

Authors:  Yuan Dong; Cheng-Bin Cui; Chang-Wei Li; Wei Hua; Chang-Jing Wu; Tian-Jiao Zhu; Qian-Qun Gu
Journal:  Mar Drugs       Date:  2014-07-29       Impact factor: 5.118

10.  Mutation, Chemoprofiling, Dereplication, and Isolation of Natural Products from Penicillium oxalicum.

Authors:  Vidushi Abrol; Manoj Kushwaha; Divya Arora; Sharada Mallubhotla; Sundeep Jaglan
Journal:  ACS Omega       Date:  2021-06-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.